跳至主要内容
临床试验/NCT06716047
NCT06716047进行中(未招募)1 期

Effects of DL-endopeptidase Produced by Probiotics on Human Intestinal NOD2 Ligands and Related Functions

Zhujiang Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年12月5日最近更新:
干预措施

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
30
试验地点
1
主要终点
safty

研究概览

简要总结

We have discovered a type of probiotic that can target activating intestinal NOD2, which is related to a series of human health issues.

详细描述

This trial requires the subjects to take probiotics for a certain period of time, and we will collect blood, stool and questionnaires for subsequent testing, efficacy evaluation and safety evaluation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者

入选标准

  • Tend to participate the trial
  • Willing to provide written informed consent

排除标准

  • Recent use of probiotics, antibiotics, laxatives, or gastrointestinal ulcer medications within the past month.
  • Gastrointestinal symptoms (e.g., constipation, abdominal pain, diarrhea, melena, hematochezia) in the past month.
  • Other conditions considered by researchers for exclusion

研究组 & 干预措施

placebo

Placebo Comparator

resistant dextrin

干预措施: Oral administration (Other)

probiotics

Experimental

lactobacillus

干预措施: Oral administration (Other)

结局指标

主要结局

safty

时间窗: up to 2 weeks

Adverse reaction by questionnaire survey

NOD2 activation level

时间窗: up to 2 weeks

the level of NOD2 activation by fecal in vitro experiments

次要结局

  • Intestinal barrier(up to 2 weeks)

研究者

发起方
Zhujiang Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Effects of DL-endopeptidase Producing Probiotics on... | 临床试验